Financial Partners Group (Kansas)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Financial Partners Group (Kansas)’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362K	Sell	3,310 -20	-0.6%	-$2.07K	0.04%	182
2026 Q1	$346K	Hold	3,330	–	–	0.04%	166
2025 Q4	$356K	Buy	+3,330	New	+$324K	0.04%	167
2024 Q4	–	Sell	-92,771	Closed	-$8.82M	–	196
2024 Q3	$8.82M	Sell	92,771 -2,340	-2%	-$222K	1.3%	21
2024 Q2	$8.7M	Buy	+95,111	New	+$8.49M	1.37%	22

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Financial Partners Group (Kansas)'s PPH Position: Q2 2026 in Review

Financial Partners Group (Kansas) reduced its VanEck Pharmaceutical ETF (PPH) stake by 0.6% in Q2 2026, selling an estimated $2.07K and leaving 3,310 shares worth $362K. The position accounts for 0.04% of the portfolio, ranked #182.

Financial Partners Group (Kansas) first reported a position in PPH in Q2 2024 and has held it in 5 quarters since. The position peaked at $8.82M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Financial Partners Group (Kansas) held 3,310 shares of VanEck Pharmaceutical ETF worth $362K as of Q2 2026.
Financial Partners Group (Kansas) sold 20 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.07K.
VanEck Pharmaceutical ETF made up 0.04% of Financial Partners Group (Kansas)'s portfolio in Q2 2026, its #182 holding.
Financial Partners Group (Kansas) first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 5 quarters since.
Financial Partners Group (Kansas)'s VanEck Pharmaceutical ETF position peaked at $8.82M in Q3 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Financial Partners Group (Kansas)'s 13F filing for Q2 2026, filed 23 Jul 2026.